| |
| |
|
| Insider
Information: |
King Andrew James |
| Relationship: |
Chief Scientific Officer |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Chinook Therapeutics Inc |
KDNY |
Chief Scientific Officer |
2023-08-11 |
0 |
2021-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-08-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(19,157) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-08-01 |
4 |
S |
$39.03 |
$45,586 |
D/D |
(1,168) |
19,157 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,333 |
20,325 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-04-03 |
4 |
AS |
$23.34 |
$116,718 |
D/D |
(5,000) |
16,992 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-04-03 |
4 |
OE |
$0.35 |
$875 |
D/D |
2,500 |
21,992 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-02-10 |
4 |
S |
$23.75 |
$56,806 |
D/D |
(2,392) |
19,492 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,803 |
21,884 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,333 |
18,325 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-01-31 |
4 |
S |
$24.68 |
$80,069 |
D/D |
(3,244) |
15,081 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-01-03 |
4 |
AS |
$25.82 |
$258,183 |
D/D |
(10,000) |
9,992 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-01-03 |
4 |
OE |
$0.35 |
$2,625 |
D/D |
7,500 |
19,992 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-10-06 |
4 |
S |
$19.69 |
$70,044 |
D/D |
(3,557) |
12,492 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-10-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,152 |
16,049 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-08-04 |
4 |
AS |
$20.00 |
$100,000 |
D/D |
(5,000) |
5,897 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-08-04 |
4 |
OE |
$0.35 |
$1,750 |
D/D |
5,000 |
10,897 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-07-11 |
4 |
AS |
$18.09 |
$90,468 |
D/D |
(5,000) |
5,897 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-07-11 |
4 |
OE |
$0.35 |
$1,750 |
D/D |
5,000 |
10,897 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-04-11 |
4 |
AS |
$15.36 |
$76,812 |
D/D |
(5,000) |
5,897 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-04-11 |
4 |
OE |
$0.35 |
$1,750 |
D/D |
5,000 |
10,897 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-02-18 |
4 |
AS |
$13.00 |
$32,500 |
D/D |
(2,500) |
5,897 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-02-11 |
4 |
S |
$12.74 |
$31,827 |
D/D |
(2,498) |
8,397 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-02-10 |
4 |
OE |
$0.35 |
$875 |
D/D |
2,500 |
6,594 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-02-10 |
4 |
AS |
$13.31 |
$33,275 |
D/D |
(2,500) |
4,094 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,801 |
10,895 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-11-09 |
4 |
AS |
$13.53 |
$67,660 |
D/D |
(5,000) |
4,094 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
